DOCETAXEL Provectis 160 mg/8 ml solution à diluer

7680704270034 CH-70427 L01CD02 07.16.1.

Active substances:

Docetaxelum

No images available

Details

Product number
7042703
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
docetaxelum 160 mg ut docetaxelum trihydricum, polysorbatum 80, acidum citricum, ethanolum anhydricum 3.16 g, ad solutionem pro 8 ml.

Articles (1)

Docetaxel Provectis 160 mg/8 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/06/2026
Professional SmPC
Français
11/06/2026
Professional SmPC
Italien
11/06/2026

Detailed composition

Substance Quantity Type Category
docetaxelum
160.0 MG Substance Wirkstoff (Principe actif)
docetaxelum trihydricum
- Substance WIZUS
polysorbatum 80
- Substance HNIDK
acidum citricum
- Substance HNIDK
ethanolum anhydricum
3.16 G Substance HBESI

Reimbursement information

Public price
CHF 428.90
Specialties list
Yes
Generic
Yes
SL addition date: 01/07/2026

Authorization holder

PROVECTIS HEALTHCARE AG

4058 Basel

Authorization information

Swissmedic authorization number
70427
Drug name
Docetaxel Provectis, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOKIN
ATC Code
L01CD02
Authorization status
Z
Dispensation category
A
First authorization
12/01/2026
Authorization expiration date
11/01/2031
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
DOCETAXEL Provectis 160 mg/8 ml solution à diluer
Description (DE)
DOCETAXEL Provectis 160 mg/8 ml Konzentrat für ein
Market launch
15/04/2026
Narcotic (BTM)
No

Other packaging sizes

DOCETAXEL Provectis 20 mg/1 ml solution à diluer p
1 DUR
GTIN: 7680704270010
View
DOCETAXEL Provectis 80 mg/4 ml solution à diluer p
1 DUR
GTIN: 7680704270027
View
Buy us a coffee Explore the data